Title of article
Refractory angina pectoris in end-stage coronary artery disease: Evolving therapeutic concepts, ,
Author/Authors
Frank C. Schoebel، نويسنده , , O.Howard Frazier، نويسنده , , Gilian A.J. Jessurun، نويسنده , , Mike J.L. De Jongste، نويسنده , , Kamuran A. Kadipasaoglu، نويسنده , , Thomas W. Jax، نويسنده , , Matthias P. Heintzen، نويسنده , , Denton A. Cooley، نويسنده , , Bodo E. Strauer، نويسنده , , Matthias Leschke، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1997
Pages
16
From page
587
To page
602
Abstract
Refractory angina pectoris in coronary artery disease is defined as the persistence of severe anginal symptoms despite maximal conventional antianginal combination therapy. Further, the option to use an invasive revascularization procedure such as percutaneous coronary balloon angioplasty or aortocoronary bypass grafting must be excluded on the basis of a recent coronary angiogram. This coronary syndrome, which represents end-stage coronary artery disease, is characterized by severe coronary insufficiency but only moderately impaired left ventricular function. Almost all patients demonstrated severe coronary triple-vessel disease with diffuse coronary atherosclerosis, had had one or more myocardial infarctions, and had undergone aortocoronary bypass grafting (70% of cases). We present three new approaches with antiischemic properties: long-term intermittent urokinase therapy, transcutaneous and spinal cord electrical nerve stimulation, and transmyocardial laser revascularization. (Am Heart J 1997;134:587-602.)
Journal title
American Heart Journal
Serial Year
1997
Journal title
American Heart Journal
Record number
530997
Link To Document